Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

UH implants Abbott's Absorb dissolving stent on coronary artery disease patient

University Hospitals Case Medical Center is among the first in the country - and the first in Ohio - to offer and deploy the Abbott Absorb stent, a completely bioresorbable stent. The Absorb stent works exactly as its traditional metallic predecessors in that it opens a blocked coronary artery, with one major exception - it dissolves completely in the body two to three years after implantation.

10 Jul 2016

Loyola among first health systems to offer absorbable stent to heart patients

Loyola Medicine will be among the first health systems in the country to offer heart patients a new stent that is absorbed by the body once it has served its purpose.

7 Jul 2016

miRNAs may improve risk prediction in CAD

Single microRNAs derived from peripheral blood predict cardiovascular mortality in patients with coronary artery disease, German research shows.

6 Jul 2016

FDA approves Absorb GT1 BVS to treat coronary artery disease

The U.S. Food and Drug Administration today approved the first fully absorbable stent to treat coronary artery disease.

5 Jul 2016

Radial access gains ground over femoral route for PCI

A meta-analysis supports that radial access delivers better outcomes and improved safety than femoral access in patients undergoing percutaneous coronary intervention.

2 Jul 2016

Genetic testing worthwhile in sudden cardiac death

Genetic testing and family screening help to provide explanations for sudden cardiac death in children and young adults, shows a population-based study.

24 Jun 2016

Athens QRS score flags false-negative exercise stress tests

Patients with a low Athens QRS score are highly likely to have coronary artery disease even if they have a normal exercise stress test, say researchers.

24 Jun 2016

AF patients at risk for stroke mostly treated with aspirin-only prescription instead of blood thinners

Researchers at University of California San Diego School of Medicine and University of California, San Francisco School of Medicine report that more than 1 in 3 atrial fibrillation (AF) patients at intermediate to high risk for stroke are treated with aspirin alone, despite previous data showing this therapy to be inferior to blood thinners.

21 Jun 2016

Diabetes-heart disease combination can increase death risk

The combination of type 2 diabetes and coronary artery disease can be deadly. New research from a global study led by a physician from UConn Health has found that patients with Type 2 diabetes admitted into the hospital for congestive heart failure face a one in four chance of dying over the next 18 months.

13 Jun 2016

Tackling Healthcare Challenges in a Changing World: an Interview with Professor Jeremy Nicholson

As individuals and as populations our risks of getting diseases are determined partly genetically and partly from the environment that we live in. An important part of that environment that mediates between the outside world and the inside world of our bodies is the microbiome.

10 Jun 2016

NMR-based metabolomics: an interview with Prof. Claudio Luchinat

Professor Claudio Luchinat, University of Florence and co-founder of the Magnetic Resonance Center (CERM), speaks to News-Medical about his research in NMR-based metabolomics.

From Bruker BioSpin - NMR, EPR and Imaging 9 Jun 2016

Artificial intelligence could refine CAD prognosis

A study shows that machine learning can predict mortality in patients with coronary artery disease with greater accuracy than models based on coronary computed tomographic angiography or clinical variables.

6 Jun 2016

Neutral atherosclerosis trial highlights effectiveness of optimal medical therapy

Salsalate has no greater effect than placebo on the progression of coronary artery plaque, show the findings of the randomised TINSAL-CVD trial.

3 Jun 2016

Right carbohydrate intake linked to healthy aging

Most people know that a diet high in fiber helps to keep us "regular." Now Australian researchers have uncovered a surprising benefit of this often-undervalued dietary component.

2 Jun 2016

$CD34+ cell therapy improves angina frequency in no option patients with class III/IV angina refractory$

CD34+ cell therapy improves angina frequency in no option patients with class III/IV angina refractory

A two-year, multi-center clinical study with 167 patients with class III-IV refractory angina randomized to low and high dose CD34+ cells or placebo has revealed that patients who received either a high or low dose of CD34 -- a member of a family of proteins that have an impact on vascular-associated tissue -- cells had a significant reduction in angina frequency over patients who received placebo.

2 Jun 2016

Women less likely to receive good anticoagulant therapy for AF-related stroke, say researchers

Female atrial fibrillation patients are less likely than their male counterparts to receive blood thinning therapies to prevent stroke, say University of Cincinnati College of Medicine researchers.

1 Jun 2016

ART alone not sufficient to reduce arterial inflammation among HIV-infected patients, study finds

Initiating antiretroviral therapy (ART) soon after diagnosis of an HIV infection did not prevent the progression of significant arterial inflammation in a small group of previously untreated patients.

26 May 2016

Higher aerobic fitness in childhood may reduce metabolic syndrome risks in early adulthood

A new study from a group of international researchers has identified a potentially effective tool to reduce the long-term health risks of childhood obesity—aerobic exercise.

24 May 2016

Novel protective gene against CAD uncovered

A large study has found that mutations in the gene encoding the major subunit of the asialoglycoprotein receptor are protective against coronary artery disease.

20 May 2016

OSA patients may have 1.57 times more MACCE risk afer unplanned revascularization

In an ongoing prospective study involving 1,311 patients from five nations, researchers found that untreated obstructive sleep apnea (OSA) was associated with increased risk of a Major Adverse Cardiac and Cerebrovascular Event (MACCE) -- cardiovascular death, non-fatal myocardial infarction (heart attack), non-fatal stroke, and unplanned revascularization such as heart bypass surgery and angioplasty.

17 May 2016

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

UH implants Abbott's Absorb dissolving stent on coronary artery disease patient

Loyola among first health systems to offer absorbable stent to heart patients

miRNAs may improve risk prediction in CAD

FDA approves Absorb GT1 BVS to treat coronary artery disease

Radial access gains ground over femoral route for PCI

Genetic testing worthwhile in sudden cardiac death

Athens QRS score flags false-negative exercise stress tests

AF patients at risk for stroke mostly treated with aspirin-only prescription instead of blood thinners

Diabetes-heart disease combination can increase death risk

Tackling Healthcare Challenges in a Changing World: an Interview with Professor Jeremy Nicholson

NMR-based metabolomics: an interview with Prof. Claudio Luchinat

Artificial intelligence could refine CAD prognosis

Neutral atherosclerosis trial highlights effectiveness of optimal medical therapy

Right carbohydrate intake linked to healthy aging

CD34+ cell therapy improves angina frequency in no option patients with class III/IV angina refractory

Women less likely to receive good anticoagulant therapy for AF-related stroke, say researchers

ART alone not sufficient to reduce arterial inflammation among HIV-infected patients, study finds

Higher aerobic fitness in childhood may reduce metabolic syndrome risks in early adulthood

Novel protective gene against CAD uncovered

OSA patients may have 1.57 times more MACCE risk afer unplanned revascularization

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in